Yoshiyama Annie 4
4 · Allogene Therapeutics, Inc. · Filed Jan 28, 2025
Insider Transaction Report
Form 4
Yoshiyama Annie
SVP, Finance
Transactions
- Award
Common Stock
2025-01-24+36,232→ 137,990 total - Award
Stock Option (Right to buy)
2025-01-24+128,093→ 128,093 totalExercise: $1.94Exp: 2035-01-24→ Common Stock (128,093 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option shall vest on January 24, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter.